Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis

BACKGROUND: The current therapies of thyroid-associated ophthalmopathy (TAO) were still a challenging matter. In this study, we aimed to contrast the impact of before- after rituximab (RTX) therapy in the patients with TAO. METHODS: We searched the PubMed, EMBASE, and SCOPUS databases for articles p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changjun, Ning, Qingyao, Jin, Kai, Xie, Jiajun, Ye, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816536/
https://www.ncbi.nlm.nih.gov/pubmed/29452583
http://dx.doi.org/10.1186/s12886-018-0679-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816536/
https://www.ncbi.nlm.nih.gov/pubmed/29452583
http://dx.doi.org/10.1186/s12886-018-0679-4

Ejemplares similares